DAX6.693-1,4%  Dow12.801-0,7%  Euro1,3200-0,7% 
ESt502.481-1,7%  Nas2.904-0,8%  Öl117,6-0,9% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.721-0,5% 
Home > Aktien > Emergent BioSolutions Aktie > Nachrichten zu Emergent BioSolutions

Emergent BioSolutions Aktie [WKN: A0LC2W / ISIN: US29089Q1058]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS FeedAnalyseim ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Emergent BioSolutions Inc.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Emergent BioSolutions Inc.

28.12.11Emergent BioSolutions: Abbott beendet Entwicklungsabkommen
11.03.10Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader
04.03.10Emergent BioSolutions Reports Financial Results for Full Year 2009
22.02.10Emergent BioSolutions to Participate in March 2010 Investor Conferences
25.01.10Emergent BioSolutions to Release Fourth Quarter and Full Year 2009 Financial Results and Conduct a Conference Call on March 4, 2010
11.01.10Emergent BioSolutions Announces R. Don Elsey, Chief Financial Officer, to Join Board of Directors of MdBio Foundation
11.01.10Emergent BioSolutions Provides Preliminary 2009 Financial Results and Guidance for 2010
08.12.09HHS Cancels RFP for rPA Procurement and Modifies Their Approach in Favor of BAA for Development of rPA Vaccines
01.12.09Former U.K. Health Protection Agency Director Rejoins Emergent BioSolutions to Head Biodefense Business
30.11.09Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
13.11.09Emergent BioSolutions Enhances Manufacturing Infrastructure with Strategic Acquisition in Baltimore
05.11.09Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2009
02.11.09Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
14.10.09Emergent BioSolutions Sponsors Security and Defence Agenda Roundtable on Biopreparedness
08.10.09Emergent BioSolutions to Release Third Quarter 2009 Financial Results and Conduct a Conference Call on November 5, 2009
30.09.09NIAID to Fund Development of Emergent BioSolutions’ Advanced Anthrax Vaccine Candidate
14.09.09Emergent BioSolutions Issues Statement on Court Ruling
04.09.09Emergent BioSolutions to Webcast Presentation at Upcoming Investor Conference
06.08.09Emergent BioSolutions Reports Financial Results for Second Quarter and First Six Months of 2009
06.08.09Emergent BioSolutions Expands Manufacturing and Development Infrastructure Through a Series of Real Estate Transactions
21.07.09Emergent BioSolutions to Release Second Quarter 2009 Financial Results and Conduct a Conference Call on August 6, 2009
19.06.09Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Winner in Greater Washington
15.06.09Emergent BioSolutions Chief Financial Officer, Don Elsey, Named SmartCFO of the Year
11.06.09Emergent BioSolutions Meets With FDA To Review Regulatory Strategy for Recombinant Anthrax Vaccine
10.06.09Emergent BioSolutions Receives FDA Approval Extending Shelf Life of BioThrax (Anthrax Vaccine Adsorbed) to 4 Years
26.05.09Emergent BioSolutions to Webcast Presentations at Upcoming Investor Conferences
20.05.09Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday, May 21, 2009 at 10:00 am Eastern
13.05.09Emergent BioSolutions Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract with HHS
13.05.09Emergent BioSolutions Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract with HHS
08.05.09Emergent BioSolutions Launches BioThrax.com, an Educational Website about BioThrax (Anthrax Vaccine Adsorbed) and Anthrax Disease
08.05.09Emergent BioSolutions Chairman and CEO, Mr. Fuad El-Hibri, Named Ernst & Young Entrepreneur of the Year 2009 Award Finalist in Greater Washington
07.05.09Emergent BioSolutions Reports Financial Results for First Quarter 2009
05.05.09Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement With ProBioGen To Explore Production Of MVA85A TB Vaccine Candidate Using AGE1.CR.pIX® Cell Line
05.05.09Oxford-Emergent Tuberculosis Consortium Signs Commercial License Agreement with Vivalis to Explore Production Of MVA85A TB Vaccine Candidate Using EB66® Cell Line
23.04.09HHS Extends Deadline for Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract to Submit Development Plan to FDA for Review to June 15, 2009
22.04.09New TB Vaccine Candidate Enters Phase IIb Proof-of-Concept Trial in South Africa
21.04.09Emergent BioSolutions to Release First Quarter 2009 Financial Results and Conduct a Conference Call on May 7, 2009
16.04.09HHS Requires Bidders in Competitive Range for Recombinant Anthrax Vaccine (rPA) Contract to Submit Development Plan to FDA for Review
17.03.09Emergent BioSolutions Announces Commencement of Phase I/II Clinical Trial of Anthrax Immune Globulin for Treating Anthrax Disease
05.03.09Emergent BioSolutions Reports Financial Results for Full Year 2008

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon